🚀 VC round data is live in beta, check it out!
- Public Comps
- IMCD
IMCD Valuation Multiples
Discover revenue and EBITDA valuation multiples for IMCD and similar public comparables like ICL Group, Syensqo, Orica, Celanese and more.
IMCD Overview
About IMCD
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.
Founded
1995
HQ

Employees
5.1K
Website
Sectors
Financials (LTM)
EV
$9B
IMCD Financials
IMCD reported last 12-month revenue of $6B and EBITDA of $638M.
In the same LTM period, IMCD generated $1B in gross profit, $638M in EBITDA, and $287M in net income.
Revenue (LTM)
IMCD P&L
In the most recent fiscal year, IMCD reported revenue of $6B and EBITDA of $633M.
IMCD expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | XXX | $6B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 25% | XXX | 25% | XXX | XXX | XXX |
| EBITDA | $638M | XXX | $633M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $287M | XXX | $257M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
IMCD Stock Performance
IMCD has current market cap of $7B, and enterprise value of $9B.
Market Cap Evolution
IMCD's stock price is $115.94.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9B | $7B | 0.0% | XXX | XXX | XXX | $4.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIMCD Valuation Multiples
IMCD trades at 1.5x EV/Revenue multiple, and 13.5x EV/EBITDA.
EV / Revenue (LTM)
IMCD Financial Valuation Multiples
As of April 19, 2026, IMCD has market cap of $7B and EV of $9B.
Equity research analysts estimate IMCD's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
IMCD has a P/E ratio of 23.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7B | XXX | $7B | XXX | XXX | XXX |
| EV (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 13.5x | XXX | 13.6x | XXX | XXX | XXX |
| EV/EBIT | 18.7x | XXX | 19.3x | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | 6.1x | XXX | XXX | XXX |
| P/E | 23.8x | XXX | 26.6x | XXX | XXX | XXX |
| EV/FCF | 23.5x | XXX | 24.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified IMCD Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


IMCD Margins & Growth Rates
IMCD's revenue in the last 12 month grew by 5%.
IMCD's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.2M for the same period.
IMCD's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IMCD's rule of X is 25% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
IMCD Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 25% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
IMCD Public Comps
See public comps and valuation multiples for other Chemicals comps.
Valuation data powered by FactSet, Inc.
IMCD M&A Activity
IMCD acquired XXX companies to date.
Last acquisition by IMCD was on XXXXXXXX, XXXXX. IMCD acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by IMCD
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIMCD Investment Activity
IMCD invested in XXX companies to date.
IMCD made its latest investment on XXXXXXXX, XXXXX. IMCD invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by IMCD
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout IMCD
| When was IMCD founded? | IMCD was founded in 1995. |
| Where is IMCD headquartered? | IMCD is headquartered in Netherlands. |
| How many employees does IMCD have? | As of today, IMCD has over 5K employees. |
| Is IMCD publicly listed? | Yes, IMCD is a public company listed on Euronext Amsterdam. |
| What is the stock symbol of IMCD? | IMCD trades under IMCD ticker. |
| When did IMCD go public? | IMCD went public in 2014. |
| Who are competitors of IMCD? | IMCD main competitors are ICL Group, Syensqo, Orica, Celanese. |
| What is the current market cap of IMCD? | IMCD's current market cap is $7B. |
| What is the current revenue of IMCD? | IMCD's last 12 months revenue is $6B. |
| What is the current revenue growth of IMCD? | IMCD revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of IMCD? | Current revenue multiple of IMCD is 1.5x. |
| Is IMCD profitable? | Yes, IMCD is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of IMCD? | IMCD's last 12 months EBITDA is $638M. |
| What is IMCD's EBITDA margin? | IMCD's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of IMCD? | Current EBITDA multiple of IMCD is 13.5x. |
| What is the current FCF of IMCD? | IMCD's last 12 months FCF is $366M. |
| What is IMCD's FCF margin? | IMCD's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of IMCD? | Current FCF multiple of IMCD is 23.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.